Status:
RECRUITING
Clinimetric Properties of Muscle Mass and Stiffness Measurements of the Quadriceps in Patients With COPD
Lead Sponsor:
Groupe Hospitalier du Havre
Conditions:
COPD
Quadriceps Muscle Atrophy
Eligibility:
All Genders
18+ years
Brief Summary
A large amount of patients with COPD suffer from muscle dysfunction characterized by losses of muscle mass and strength. Studies have shown an association between a loss of quadriceps muscle mass and ...
Detailed Description
Muscle dysfunction in COPD is characterized by reduced skeletal muscle mass and strength, particularly in the lower limbs. These systemic consequences of COPD play a key role in the course of these pa...
Eligibility Criteria
Inclusion
- COPD patients
- Adults (\>18 years old)
- Patients starting a pulmonary rehabilitation (PR) programme
Exclusion
- Patients included in other research protocol
- Minors or under guardianship
- Pregnancy
- Patients with lower limb amputation or history of neuromuscular disease
- Cardiovascular contradications for PR
Key Trial Info
Start Date :
May 30 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06994689
Start Date
May 30 2025
End Date
December 1 2026
Last Update
May 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier du Havre
Le Havre, France, 76290